Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters.

Karimi, Masoud; Osterlund, Pia; Hammarström, Klara; Imam, Israa; Frodin, Jan-Erik; Glimelius, Bengt

Karimi, Masoud; Osterlund, Pia; Hammarström, Klara; Imam, Israa; Frodin, Jan-Erik; Glimelius, Bengt.

Afiliación

Karimi M; Department of Gastrointestinal Oncology, Karolinska University Hospital, 171 64 Stockholm, Sweden.
Osterlund P; Department of Oncology and Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Hammarström K; Department of Gastrointestinal Oncology, Karolinska University Hospital, 171 64 Stockholm, Sweden.
Imam I; Department of Oncology and Pathology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Frodin JE; Department of Oncology, Tampere University Hospital, University of Tampere, 33520 Tampere, Finland.
Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, 752 36 Uppsala, Sweden.

Cancers (Basel) ; 14(24)2022 Dec 18.

Article en En | MEDLINE | ID: mdl-36551723

Palabras clave

pathologic complete remission; pre-operative treatment; predictive factors; rectal cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google